Pharmint

Case Study

Opportunities in the Business-to-Government (B2G) Market for Pharma Imports in Africa

Africa’s healthcare sector is expanding rapidly, with governments increasing investment in pharmaceutical imports to improve public healthcare systems. As demand for generic medicines, vaccines, medical equipment, and diagnostic kits rises, the Business-to-Government (B2G) market presents a lucrative opportunity for global pharma manufacturers and exporters. For Indian pharmaceutical companies, Africa is a key market for supplying […]

Opportunities in the Business-to-Government (B2G) Market for Pharma Imports in Africa Read More »

How Global Tariffs Impact B2B Cross-Border Pharma Trade & How Pharmint Helps Buyers Navigate It

In the B2B cross-border pharmaceutical trade, tariffs play a significant role in determining the cost, accessibility, and competitiveness of medicines and medical supplies. Countries impose import and export duties on pharmaceuticals, impacting the price of everything from generic medicines and biosimilars to bulk chemicals and medical equipment. For global B2B pharma buyers, understanding how tariffs

How Global Tariffs Impact B2B Cross-Border Pharma Trade & How Pharmint Helps Buyers Navigate It Read More »

Biosimilar, Generic, and Branded Pharma: Understanding the Key Differences in B2B Global Pharma Trade

In the world of B2B cross-border pharma trade, understanding the differences between biosimilars, generics, and branded pharmaceuticals is crucial for bulk pharma buyers, wholesalers, and international distributors. Each category plays a distinct role in the global pharmaceutical supply chain, influencing pricing, regulatory requirements, and trade opportunities. For global buyers sourcing medicines from India’s top pharmaceutical

Biosimilar, Generic, and Branded Pharma: Understanding the Key Differences in B2B Global Pharma Trade Read More »

The Importance of Certificate of Analysis (CoA) in B2B Cross-Border Pharma Trade

Ensuring Quality & Compliance in Global Pharma Trade In the highly regulated world of B2B cross-border pharma trade, ensuring the quality, safety, and efficacy of pharmaceutical products is crucial. One of the most important documents that helps achieve this is the Certificate of Analysis (CoA). This document is essential for pharmaceutical bulk buyers, pharma distributors,

The Importance of Certificate of Analysis (CoA) in B2B Cross-Border Pharma Trade Read More »

𝐖𝐡𝐲 𝐀𝐟𝐫𝐢𝐜𝐚’𝐬 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐀𝐧𝐭𝐢𝐦𝐚𝐥𝐚𝐫𝐢𝐚𝐥 𝐃𝐫𝐮𝐠𝐬 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐬 𝐭𝐨 𝐆𝐫𝐨𝐰

Malaria remains one of the biggest public health challenges in Africa, driving the constant demand for antimalarial drugs across the continent. With a significant portion of the world’s malaria cases occurring in Africa, the cross-border pharma trade plays a crucial role in ensuring a steady supply of these life-saving medicines. Companies like Pharmint, a leading

𝐖𝐡𝐲 𝐀𝐟𝐫𝐢𝐜𝐚’𝐬 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐀𝐧𝐭𝐢𝐦𝐚𝐥𝐚𝐫𝐢𝐚𝐥 𝐃𝐫𝐮𝐠𝐬 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐬 𝐭𝐨 𝐆𝐫𝐨𝐰 Read More »

10 Key Points to Ensure Quality Assurance in Cross-Border Pharma Trade

In cross-border B2B pharma trade, ensuring quality assurance is essential for the safety, efficacy, and regulatory compliance of medicines and medical supplies. International buyers face multiple challenges, from verifying supplier credibility to ensuring products meet stringent WHO-GMP, US FDA, and EU GMP standards. Pharmint, a leading B2B pharma marketplace in India, simplifies this process by

10 Key Points to Ensure Quality Assurance in Cross-Border Pharma Trade Read More »

How Contract Manufacturing is Driving India’s Dominance in Global B2B Cross-Border Pharma Trade

India has emerged as the global leader in contract manufacturing for the pharmaceutical industry, supplying high-quality, cost-effective medicines to regulated and semi-regulated markets worldwide. With increasing demand from Africa, Europe, Latin America, and the Middle East, contract manufacturing is fueling India’s dominance in B2B cross-border pharma trade. Leading B2B pharma marketplaces in India, like Pharmint,

How Contract Manufacturing is Driving India’s Dominance in Global B2B Cross-Border Pharma Trade Read More »

The Future of Pharma Wholesale Distribution: Digital Transformation & Marketplaces

The pharmaceutical industry is witnessing a massive shift, with digital transformation revolutionizing pharma wholesale distribution worldwide. Traditional medicine B2B wholesale India online models relied heavily on manual transactions, intermediaries, and outdated processes. Today, with B2B online wholesale medicine supply for pharmacy, buyers and sellers are experiencing faster, more transparent, and cost-effective trade solutions. Leading online

The Future of Pharma Wholesale Distribution: Digital Transformation & Marketplaces Read More »

The Growing Demand for Biosimilars & How Pharmint Simplifies Global Sourcing

The Growing Demand for Biosimilars & How Pharmint Simplifies Global Sourcing

Why Biosimilars are Transforming the Global Pharmaceutical Market The biosimilars industry is experiencing rapid growth as healthcare systems worldwide seek cost-effective alternatives to expensive biologic drugs. With patent expirations of blockbuster biologics, the global demand for biosimilars is soaring, particularly in oncology, autoimmune diseases, diabetes, and cardiovascular conditions. For B2B pharma buyers, sourcing high-quality biosimilars

The Growing Demand for Biosimilars & How Pharmint Simplifies Global Sourcing Read More »

The Growing Demand for Radiopharmaceuticals in Global Pharma Trade

Pharmint: Simplifying Global Sourcing for Radiopharmaceuticals Radiopharmaceuticals, or radioactive drugs used for diagnosis and treatment, are experiencing significant global demand due to advancements in medical imaging and targeted therapies. With the rise of cancer treatments, nuclear medicine, and PET-CT scans, the need for high-quality radiopharmaceuticals is growing worldwide. As B2B pharma buyers, hospitals, and research

The Growing Demand for Radiopharmaceuticals in Global Pharma Trade Read More »

Scroll to Top